Nerich V, Falcoz A, Nadin L, Meurisse A, et al. Cost-minimization analysis of the GORTEC 2014-04 randomized phase II study of stereotactic ablative radiotherapy (SABR) or chemotherapy-SABR in oligometastatic head and neck cancer. Radiother Oncol 2025;204:110726.
PMID: 39837424